PSAP and adenocarcinoma: A comprehensive immunohistochemical panel to differentiate small cell carcinoma from poorly differentiated adenocarcinoma includes PSA, PSAP, P501s, and neuroendocrine markers, CD 56 being the most sensitive for small cell carcinoma (Figures 5 and 6).